SCHEMBL7539478

SCHEMBL7539478

CS(=O)(=O)c1ccc(-c2ncccc2-c2cc(F)cc(F)c2)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.48
PTGS1 P23219 2/20 0.48
GRM4 Q14833 1/20 0.41
FEN1 P39748 8/20 0.40
ALOX5AP P20292 6/20 0.40
SYK P43405 1/20 0.40
KMO O15229 1/20 0.39
TDP2 O95551 1/20 0.38
NSD2 O96028 1/20 0.38
ABL1 P00519 1/20 0.38
PLCG1 P19174 1/20 0.38
CES1 P23141 1/20 0.38
PAX8 Q06710 1/20 0.38
RIN1 Q13671 1/20 0.38
GAA P10253 1/20 0.38
GLO1 Q04760 1/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7545154 0.91 PTGS2 (0.52) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7543109 0.90 PTGS2 (0.49) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7048786 0.89 PTGS2 (0.47) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7546260 0.89 PTGS2 (0.47) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7546410 0.88 PTGS2 (0.49) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7545150 0.88 PTGS2 (0.63) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7539240 0.88 PTGS2 (0.46) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7543956 0.88 PTGS2 (0.46) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7537374 0.87 PTGS2 (0.51) PTGS2PTGS1GRM4FEN1ALOX5AP
SCHEMBL7544733 0.87 PTGS2 (0.51) PTGS2PTGS1GRM4FEN1ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2002-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, FPR1, PTGES2 PTGS2 5/4885PTGS1 4/4885GRM4 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.